一项关于血清脂质水平与系统性红斑狼患者疾病活动之间的相关性研究
Lu Li1,2, Lin-Lin Li1,2, Yang Dong3
1Department of Nephrology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.
Kidney & blood pressure research
|September 26, 2025
概括
系统性红斑狼 (SLE) 患者常见的失脂症,脂质水平与疾病活动相关,并预测脏参与. 监测脂质和炎症对于管理SLE至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 临床化学 临床化学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性红斑狼 (SLE) 的发病过程复杂,有新出现的证据将异常的脂质代谢与疾病发展联系起来.
- 血脂失调症的特征是血脂水平异常,越来越多地被认为是SLE的潜在因素.
- 了解脂质配置文件和SLE活动之间的关系对于患者管理至关重要.
研究的目的:
- 为了调查诊断为SLE的患者中脱脂症的患病率.
- 分析脂质代谢异常与SLE疾病活性之间的相关性.
- 评估脂质参数在预测SLE患者参与方面的潜力.
主要方法:
- 一组由174名SLE患者组成的队列被追溯研究.
- 收集了临床数据和实验室指标,包括血清脂质水平.
- 进行了统计分析,以基于脂质水平的SLE患者进行比较,并将其与疾病标志物相关联.
主要成果:
- 观察到高血脂不良 (92.53%) 的高患病率,主要是低高密度脂蛋白胆固醇 (HDL) 和高甘油三 (TG).
- 脂质水平与炎症标志物 (例如,WBC,SII) 和SLE疾病活性评分 (SLEDAI-2K) 显示出正相关性.
- 特定的脂质配置文件 (TC,TG,LDL) 显示了狼性炎的预测价值,联合检测显示了增强的歧视.
结论:
- 脱脂症在SLE患者中非常普遍,并且与疾病活动和炎症有关.
- 血清脂类水平作为预测SLE参与的信息指标.
- 建议定期监测脂质样本和炎症标志物,以及降脂疗法,用于SLE管理.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
555
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
555
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Lipids: Dietary Sources and Requirements
1.8K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
470
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
470
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
492
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
492


